[HTML][HTML] Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy

Y Iwakiri, J Trebicka - JHEP reports, 2021 - Elsevier
Portal hypertension, defined as increased pressure in the portal vein, develops as a
consequence of increased intrahepatic vascular resistance due to the dysregulation of liver …

Pleiotropic effects of statins on the cardiovascular system

A Oesterle, U Laufs, JK Liao - Circulation research, 2017 - Am Heart Assoc
The statins have been used for 30 years to prevent coronary artery disease and stroke. Their
primary mechanism of action is the lowering of serum cholesterol through inhibiting hepatic …

Hepatic microcirculation and mechanisms of portal hypertension

J Gracia-Sancho, G Marrone… - Nature reviews …, 2019 - nature.com
The liver microcirculatory milieu, mainly composed of liver sinusoidal endothelial cells
(LSECs), hepatic stellate cells (HSCs) and hepatic macrophages, has an essential role in …

Liver sinusoidal endothelial cells in hepatic fibrosis

LD DeLeve - Hepatology, 2015 - journals.lww.com
Capillarization, lack of liver sinusoidal endothelial cell (LSEC) fenestration, and formation of
an organized basement membrane not only precedes fibrosis, but is also permissive for …

Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction

C Engelmann, J Clària, G Szabo, J Bosch… - Journal of …, 2021 - Elsevier
Patients with acutely decompensated cirrhosis have a dismal prognosis and frequently
progress to acute-on-chronic liver failure, which is characterised by hepatic and extrahepatic …

Sinusoidal communication in liver fibrosis and regeneration

G Marrone, VH Shah, J Gracia-Sancho - Journal of hepatology, 2016 - Elsevier
Cellular crosstalk is a process through which a message is transmitted within an individual
cell (intracellular crosstalk) or between different cells (intercellular crosstalk). Intercellular …

Pathophysiology of portal hypertension

Y Iwakiri, RJ Groszmann - The Liver: Biology and Pathobiology, 2020 - Wiley Online Library
The most frequent cause of portal hypertension is liver cirrhosis, and many of lethal
complications of cirrhosis such as ascites and gastroesophageal variceal hemorrhage are …

Experimental liver fibrosis research: update on animal models, legal issues and translational aspects

C Liedtke, T Luedde, T Sauerbruch, D Scholten… - Fibrogenesis & tissue …, 2013 - Springer
Liver fibrosis is defined as excessive extracellular matrix deposition and is based on
complex interactions between matrix-producing hepatic stellate cells and an abundance of …

[HTML][HTML] Vascular pathobiology in chronic liver disease and cirrhosis–current status and future directions

Y Iwakiri, V Shah, DC Rockey - Journal of hepatology, 2014 - Elsevier
Chronic liver disease is associated with remarkable alterations in the intra-and extrahepatic
vasculature. Because of these changes, the fields of liver vasculature and portal …

Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis

JG Abraldes, C Villanueva, C Aracil, J Turnes… - Gastroenterology, 2016 - Elsevier
Background & Aims The combination of βべーた-blockers and band ligation is the standard
approach to prevent variceal rebleeding, but bleeding recurs and mortality is high. The lipid …